Health
Sanofi’s mRNA COVID-19 vaccine candidate not ready this year – CEO By Reuters – Investing.com UK
Sanofi’s mRNA COVID-19 vaccine candidate not ready this year – CEO
PARIS (Reuters) – A COVID-19 vaccine candidate developed by Sanofi (PA:SASY) and U.S. group Translate Bio “will not be ready this year,” the French drugmaker’s chief executive told Le Journal du Dimanche newspaper.
Clinical trials of this vaccine, which will be based on a technology known as mRNA — on which lean approved vaccines of Pfizer/BioNTech and Moderna (NASDAQ:MRNA) –, are expected to start this quarter.
In December last year, Sanofi had said it was targeting “earliest potential approval”…
-
General12 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News21 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News13 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General14 hours agoPerth man charged after investigation into organised crime and tobacco store attacks